Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
11.43 USD | -0.26% | -0.87% | +8.55% |
Sales 2024 * | 263M 21.04B | Sales 2025 * | 344M 27.49B | Capitalization | 715M 57.13B |
---|---|---|---|---|---|
Net income 2024 * | -36M -2.87B | Net income 2025 * | -8M -639M | EV / Sales 2024 * | 3.13 x |
Net Debt 2024 * | 108M 8.62B | Net Debt 2025 * | 109M 8.7B | EV / Sales 2025 * | 2.39 x |
P/E ratio 2024 * |
-18.4
x | P/E ratio 2025 * |
-83.6
x | Employees | 273 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 80.49% |
Latest transcript on Evolus, Inc.
1 day | -0.26% | ||
1 week | -0.87% | ||
Current month | -18.36% | ||
1 month | -18.36% | ||
3 months | -4.27% | ||
6 months | +48.25% | ||
Current year | +8.55% |
Managers | Title | Age | Since |
---|---|---|---|
David Moatazedi
CEO | Chief Executive Officer | 46 | 05/05/18 |
Sandra Beaver
DFI | Director of Finance/CFO | 46 | 04/09/22 |
Rui Avelar
CTO | Chief Tech/Sci/R&D Officer | 62 | 31/12/13 |
Members of the board | Title | Age | Since |
---|---|---|---|
David Gill
BRD | Director/Board Member | 69 | 11/02/18 |
Simone Blank
BRD | Director/Board Member | 61 | 31/12/17 |
Robert Hayman
BRD | Director/Board Member | 65 | 31/12/17 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.00% | 9 M€ | +6.26% | - |
Date | Price | Change | Volume |
---|---|---|---|
26/04/24 | 11.43 | -0.26% | 796,551 |
25/04/24 | 11.46 | -0.35% | 548,254 |
24/04/24 | 11.5 | -1.71% | 262,580 |
23/04/24 | 11.7 | -0.17% | 405,768 |
22/04/24 | 11.72 | +1.65% | 339,146 |
Delayed Quote Nasdaq, April 26, 2024 at 09:00 pm
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+8.55% | 715M | |
+25.83% | 661B | |
+27.00% | 566B | |
-6.76% | 352B | |
+20.34% | 332B | |
+3.00% | 283B | |
+13.09% | 231B | |
+5.46% | 200B | |
-9.61% | 195B | |
-6.26% | 145B |
- Stock Market
- Equities
- EOLS Stock